There is provided a system (100) and method for determining a water or lipid level of skin. The system (100) comprises at least two electrodes (108) suitable for contacting skin, and a signal generator (106) configured to generate an electrical signal at a frequency across the at least two electrodes (108). The system (100) is configured to measure a conductivity between the at least two electrodes (108). The system (100) is further configured to determine a water or lipid level of skin based on the measured conductivity and the frequency of the electrical signal.

There is provided a system (100) and method for determining a water or lipid level of skin. The system (100) comprises at least two electrodes (108) suitable for contacting skin, and a signal generator (106) configured to generate an electrical signal at a frequency across the at least two electrodes (108). The system (100) is configured to measure a permittivity between the at least two electrodes (108). The system (100) is further configured to determine a water or lipid level of skin based on the measured permittivity and the frequency of the electrical signal.

A system and method for determining the weight gain trend of a user. The weekly weight oscillation is determined, and a future weight trend can be predicted. At least three weeks of weight oscillation trends are typically used to predict future weight trends.

The invention relates to a device for determining the driving behavior of a driver, the device comprising at least means for receiving data from two or more data sources, of which at least one produces data relating to changes in the state of motion of a vehicle and at least one other produces measured data on the well-being of the driver; means for scoring the received data by comparing it with data-specific reference values; means for forming a respective sub-index from each scored item of data; means for determining a driving behavior index on the basis of the formed sub-indices; and means for controlling control equipment of the vehicle on the basis of the driving behavior index and/or for storing the driving behavior index in a database.

The present disclosure relates to a system and a method for determining the dry weight of a patient after dialysis therapy, wherein the patient's blood volume is monitored and blood volume values are output. The blood volume values are recorded and evaluated for a predetermined period of time after reaching an ultrafiltration volume appropriately predetermined for the patient, wherein the dry weight of the patient then is determined on the basis of the rate of change of the blood volume during the predetermined period of time.

A method, system, apparatus, and/or device that may include: a first sensor operable to take a first physiological measurement; a second sensor operable to take a second physiological measurement; and a processing device operatively coupled to the first sensor and the second sensor. The processing device may be operable to: receive a first measurement data for the first physiological measurement; receive a second measurement data for the second physiological measurement; generate an event data set based on the first measurement data with the second measurement data; determine an event occurred based on the event data set; determine a type of the event; and in response to the event being a safety event: determine a type of the safety event; identify a risk level of the safety event; and in response to the risk level exceeding a threshold level, notify a second device of the safety event.

Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.

A wearable device includes a housing with a window and an electronic module supported by the housing. The electronic module includes a photoplethysmography sensor, a motion sensor, and a signal processor that processes signals from the motion sensor and signals from the photoplethysmography sensor. The signal processor is configured to remove frequency bands from the photoplethysmography sensor signals that are outside of a range of interest using a band-pass filter to produce pre-conditioned signals, and to further process the pre-conditioned signals using the motion sensor signals to reduce motion artifacts from footsteps during subject running. The device includes non-air light transmissive material in optical communication with the photoplethysmography sensor and the window that serves as a light guide for the photoplethysmography sensor. The window optically exposes the photoplethysmography sensor to a body of a subject wearing the device via the non-air light transmissive material.

The present invention is directed to a wearable system wherein elements of the system, including various sensors adapted to detect biometric and other data and/or to deliver drugs, are positioned proximal to, on the ear or in the ear canal of a person. In embodiments of the invention, elements of the system are positioned on the ear or in the ear canal for extended periods of time. For example, an element of the system may be positioned on the tympanic membrane of a user and left there overnight, for multiple days, months, or years. Because of the position and longevity of the system elements in the ear canal, the present invention has many advantages over prior wearable biometric and drug delivery devices.

Disclosed are instruments and methods for acquiring co-registered orthogonal fluorescence and photoacoustic volumetric projections of an interrogated object. In an embodiment, an instrument includes a rotary mechanism configured to rotate an interrogated object relative to an array of photoacoustic transducers and an optical detector. An optical excitation unit is configured to irradiate the interrogated object with pulses of light, inducing both fluorescence and photoacoustic responses inside the interrogated object at each of a plurality of rotational positions. The array of photoacoustic transducers includes unfocused elements arranged in a pattern along an axis of rotation, the elements configured to detect photoacoustic signals generated inside the volume of the interrogated object. The optical detector is arranged opposite to the array of photoacoustic transducers with respect to the axis of rotation and is configured to register sources of fluorescence excited inside the interrogated object. Each of the optical excitation axes form with each of the optical detection axes, and with each of the photoacoustic detection axes, angles that are between 60° and 90° so as to enable acquisition of co-registered orthogonal fluorescence and photoacoustic volumetric projections of the interrogated object.